· Public charity
Fight Colorectal Cancer Inc
Fight colorectal cancer, inc.
What you funded, over time
Every grant placed by its stated purpose and the recipient’s mission, by year — across FY2017–2025.
Where the money goes
Your grants by size, and where they go.
The 4 grants below total $458,300 — the rows itemised in this filing. The $471,300 headline is the total grant expense reported on the return, so the remaining $13,000 is giving the schedule does not break out: grants under the $5,000 itemisation floor, grants to individuals, and grants reported on other schedules. Every figure below describes the itemised rows only.
By grant size · FY2025
- $10k–50k2 grants · $33k
- $50k–250k1 grant · $75k
- $250k+1 grant · $350k
| Recipient | Amount |
|---|---|
| FIRST ASCENT BIOMEDICAL | $350,000 |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK | $75,000 |
| GEORGIA CENTER FOR ONCOLOGY RESEARCH & EDUCATION | $17,500 |
| NEVADA CANCER COALITION | $15,800 |
Do your dollars go where the need is?
Each grant placed by the hardship in its grantee’s ZIP, then read against the area’s typical level.
Dollar for dollar, your grants (FY17–25) land where the poverty rate runs at 13%, against an area that typically sits at 10%. 82% of your dollars go to grantees based in above-average-need neighborhoods. Most of your grants land in higher-need ZIPs.
Matched: human-services grants are those whose grantee’s IRS cause code is Human Services. Placed by people below the poverty linein the grantee’s ZIP, averaged from the tracts in that ZIP; grantee ZIP can differ from where services are delivered.
Which US states your grants reach
US grants placed by each grantee’s ZIP, which can differ from where services are actually delivered. Need from public data — U.S. Census/ACS, CDC PLACES, Eviction Lab, USDA — shown as context about the area, never attributed to your giving.
Who you back again
Which organizations you funded more than once, and which you funded a single time. Each grantee is matched to its own filings.
And the relationships you keep tend to grow: grantees you re-up on have seen median revenue of +57% since the first grant, against +28% for the ones you funded once.
6 repeat relationships — 0 still active in FY2025, 6 since wound down; 4 grantees were first funded in FY2025 (too recent to call).
How the two cohorts compare
Organizations
Total granted
Median revenue growth · since first grant
Still filing today
New vs renewed · share of each year
In FY2025, 0% of grant dollars renewed an existing relationship; $458k went to new ones.
First-time = a grantee’s first year in your filing window; renewed = funded in an earlier year too. As a portfolio matures the renewed share naturally climbs — once funded, an org stays “renewable” — so the signal is the years that buck it (a new-grantee intake wave). The earliest year is left-censored: relationships that predate the data read as “new.” Theme is the grantee’s IRS cause.
Backed again, and grew
- TITRAILHEAD INSTITUTE2× · 2020–2021 · $43k · revenue +57%
- CGCOLLABORATIVE GROUP OF THE AMERICAS INHERITED GASTROINTESTINAL CANCER2× · 2022–2023 · $37k · revenue +65%
- NCNATIONAL COMPREHENSIVE CANCER NETWORK2× · 2017–2019 · $18k · revenue +61%
Funded once
- CRCANCER RESEARCH INSTITUTE INCgraduatedone grant, 2017 · $100k · revenue +43%
- TFTHE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCHgraduatedone grant, 2019 · $55k · revenue +28%
- CCCALIFORNIA COLORECTAL CANCER COALITIONgraduatedone grant, 2020 · $40k · revenue +288% · 35% of their budget
Repeat = funded in two or more distinct years; growth and survival are read from each grantee’s own subsequent IRS filings.
The map has a center of gravity: the average direction from the rest of the sector toward the organizations the foundation funds — the shape of its giving. Scoring every nonprofit along that direction surfaces the ones that look most like the portfolio. These are the closest matchesthat aren’t grantees — a resemblance in what they say they do, not a recommendation.
To help conquer cancer and other diseases through the application of biostatistical principles and innovative data management methods.
Break through cancer is a foundation dedicated to supporting translational research in the most difficult to treat cancers. our partner organizations are among the top cancer research centers and together, represent some of the most…
Asco association promotes the common business interests of its members by: (1) advocating for policies that improve the quality of cancer care; (2) maintaining the highest standards of oncology medical care through programs supporting…
See schedule o:asco is a professional oncology society committed to conquering cancer through research, education, and promotion of the highest quality patient care.
Cancer research.
To support cancer research and public education relating to prevention, earlier diagnosis, better treatments and ultimately, a cure for cancer.
To aid the alliance for clinical trials in oncology national clinical trials cooperative group and support the clinical trials and laboratory research of the alliance, as well as efforts to educate the medical community on methods of…
The mission of the acr foundation is to advance the profession and practice of radiology to benefit patients with a specific emphasis on health policy research.
Conquer cancer funds research for every type of cancer to benefit every patient, everywhere. working in collaboration with a global network of top scientists and clinicians, and leading advocacy and research organizations, conquer cancer…
To bring the benefits of cancer research to physicians and their patients by offering the latest advancements in cancer prevention and treatment research available through cancer clinical trials.
Through philanthropy, the nccn foundation empowers people through knowledge and advances the mission of nccn to define and advance quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives.
For reference, the grantee most central to the portfolio’s shape is National Comprehensive Cancer Network and the most unlike its peers is The Feinstein Institutes for Medical Research. Resemblance is measured on each organization’s own IRS 990 mission text; it reflects how work is described, not its quality or impact.
14 grantees tracked through their own filings, 2017–2025.
Each one resolved to its own IRS returns and tracked year by year — your grant beside their revenue from every source. Association, dated; never a causal claim.
Counted here: distinct organizations you funded across 2017–2025, not grant rows in a single year — so this will not match the grant count on the cover. 14 of the 16 grantees resolved in that span have returns of their own we could reconcile; the rest are funded organizations whose filings we could not track year by year.
Where your money sits — by cause, then by grantee
Each org by its size and your share of it — top-left is where you’re load-bearing
Go grantee by grantee — a decade per org, and how each moved after you funded them
A decade per grantee — revenue shaded, your grants as bars, all rows on one timeline.
- Who funds AMERICAN CANCER SOCIETY INC ↗
- Who funds MAYO CLINIC ↗
- Who funds CANCER RESEARCH INSTITUTE INC ↗
- Who funds AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC ↗
- Who funds NEBRASKA CANCER COALITION ↗
- Who funds THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH ↗
- Who funds TRAILHEAD INSTITUTE ↗
- Who funds CALIFORNIA COLORECTAL CANCER COALITION ↗
- Who funds COLLABORATIVE GROUP OF THE AMERICAS INHERITED GASTROINTESTINAL CANCER ↗
- Who funds GOOD HEALTH IDEAS INC DBA COLON CANCER PREVENTION PROJECT ↗
- Who funds LSU HEALTH FOUNDATION NEW ORLEANS ↗
- Who funds NATIONAL COMPREHENSIVE CANCER NETWORK ↗
- Who funds GEORGIA CENTER FOR ONCOLOGY RESEARCH AND EDUCATION INC ↗
- Who funds NEVADA CANCER COALITION ↗
The grantmakers whose grantees overlap with yours far more than size alone predicts. Each orbits closer the stronger the alignment; the arcs between them show where they also fund each other. Here it reads as a set of overlaps that mostly run through you, not between each other.
Open a dossier: Amazonsmile Foundation
Affinity is a Gamma-Poisson posterior co-funding rate, re-centered on the typical rate, so thin evidence shrinks toward no signal. A research starting point: overlap is association, not proof of shared intent.
Government reliance of your grantees
Every dot is one organization Fight Colorectal Cancer Inc funds. Left–right is the share of its income from government; up–down is the share from you. Bigger dots raise more. Filter to federal or a single department — and drag the year to watch it move.
Government income is each org’s traced federal awards (USASpending — grants and contracts) plus state payments (open checkbooks) as a share of its total revenue (IRS Form 990); the self-reported government-grant line (990 line 1e) is carried for cross-check: a grantee that reports government grants we could not trace to a source is left off the chart rather than shown as receiving none. An association, not a claim that your grant caused the public funding. Coverage is precision-first — a floor, not a census; state records exist for 9 states, so a grantee outside them shows no state figure (dimmed) rather than a false zero. Federal award amounts are obligations, which can span years, so a single-year share is indicative. 990 filings lag 12–24 months.